Avery Dennison (AVY) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
4 Aug, 2026Executive summary
Achieved strong Q2 2026 results with adjusted EPS of $2.89, up 19% year-over-year, and organic sales growth of 8%.
Net sales reached $2.5 billion, with robust adjusted free cash flow of $365 million.
Customer inventory pre-buys contributed significantly to results, accounting for about half of organic sales growth and $0.25 of EPS.
Growth was balanced across base and high-value categories, with innovation and operational agility driving performance.
Returned $347 million to shareholders year-to-date through share repurchases and dividends.
Financial highlights
Q2 2026 adjusted EPS was $2.89, up 19% year-over-year; adjusted EBITDA margin expanded to 17.1%, up 50 bps.
Net sales increased 10.9% year-over-year to $2.5 billion; organic sales growth was 7.6%-8%.
Adjusted free cash flow for Q2 was $365 million, nearly doubling year-over-year.
Returned over $210 million to shareholders in Q2 via dividends and share repurchases; $347 million year-to-date.
Net debt to adjusted EBITDA ratio at quarter end: 2.3x.
Outlook and guidance
Full-year 2026 adjusted EPS expected at $10.00–$10.30, representing 7% growth at midpoint.
Anticipates 3%-4% organic sales growth and 5%-6% reported sales growth for 2026.
Majority of customer inventory destocking expected in Q3, leading to a sequential earnings decline of ~$0.50.
Expects high single-digit year-over-year raw material inflation in the second half.
Targeting ~100% adjusted free cash flow conversion; capital spend of ~$260 million.
Latest events from Avery Dennison
- High-value categories drive growth and margin expansion, supporting strong financial performance.AVY
Investor presentation - High-value categories and Intelligent Labels drive growth, margin expansion, and strong returns.AVY
Investor presentation - Director elections, compensation, and auditor ratified; dividend raised; governance proposal failed.AVY
AGM 2026 - Adjusted EPS up 7.4% to $2.47, with strong sales, cash flow, and Materials Group growth.AVY
Q1 2026 - Board recommends against independent chairman proposal, highlights strong 2025 results and ESG progress.AVY
Proxy filing - Board recommends all director nominees, executive pay, and auditor ratification; opposes independent Chairman proposal.AVY
Proxy Filing - FY25 adjusted EPS up 1% to $9.53, with $8.9B sales and $861M returned to shareholders.AVY
Q4 2025 - Q1 2025 organic sales up 2.3%, adjusted EPS up ~4% ex-currency, outlook cautious.AVY
Q1 2025 - 19% adjusted EPS growth in 2024 and strong 2025 outlook with margin expansion.AVY
Q4 2024